Kevin Fischbeck
Stock Analyst at B of A Securities
(4.05)
# 508
Out of 4,876 analysts
165
Total ratings
66.39%
Success rate
5.61%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Neutral | $320 → $260 | $241.88 | +7.49% | 15 | Jun 17, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $165 → $180 | $173.63 | +3.67% | 5 | May 14, 2025 | |
| UNH UnitedHealth Group | Downgrades: Neutral | $560 → $350 | $309.11 | +13.23% | 22 | May 14, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Buy | $50 → $45 | $21.90 | +103.20% | 6 | Feb 28, 2025 | |
| HCA HCA Healthcare | Maintains: Buy | $380 → $370 | $379.30 | -2.45% | 9 | Jan 27, 2025 | |
| ARDT Ardent Health | Downgrades: Neutral | $22 → $19 | $13.68 | +38.89% | 2 | Nov 6, 2024 | |
| AMN AMN Healthcare Services | Downgrades: Underperform | $65 → $48 | $20.88 | +129.89% | 4 | Oct 7, 2024 | |
| AGL agilon health | Downgrades: Underperform | $3 | $2.31 | +29.87% | 2 | Oct 2, 2024 | |
| DVA DaVita | Maintains: Underperform | $139 → $145 | $141.67 | +2.35% | 12 | Aug 7, 2024 | |
| ELV Elevance Health | Downgrades: Neutral | $646 → $530 | $381.49 | +38.93% | 3 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $297.05 | +47.79% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $9.55 | -31.94% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $13.85 | -47.65% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $79 → $72 | $53.99 | +33.36% | 11 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $326.31 | +7.26% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $183 | $178.08 | +2.76% | 14 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $21.95 | +105.01% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $74 | $122.20 | -39.44% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.39 | +62.24% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $15.27 | +129.21% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.76 | +262.32% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $12.79 | -41.36% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $32.25 | -44.19% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $14.03 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $28.00 | -32.14% | 2 | Feb 9, 2018 |
Humana
Jun 17, 2025
Maintains: Neutral
Price Target: $320 → $260
Current: $241.88
Upside: +7.49%
Tenet Healthcare
May 14, 2025
Maintains: Buy
Price Target: $165 → $180
Current: $173.63
Upside: +3.67%
UnitedHealth Group
May 14, 2025
Downgrades: Neutral
Price Target: $560 → $350
Current: $309.11
Upside: +13.23%
Acadia Healthcare Company
Feb 28, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $21.90
Upside: +103.20%
HCA Healthcare
Jan 27, 2025
Maintains: Buy
Price Target: $380 → $370
Current: $379.30
Upside: -2.45%
Ardent Health
Nov 6, 2024
Downgrades: Neutral
Price Target: $22 → $19
Current: $13.68
Upside: +38.89%
AMN Healthcare Services
Oct 7, 2024
Downgrades: Underperform
Price Target: $65 → $48
Current: $20.88
Upside: +129.89%
agilon health
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $2.31
Upside: +29.87%
DaVita
Aug 7, 2024
Maintains: Underperform
Price Target: $139 → $145
Current: $141.67
Upside: +2.35%
Elevance Health
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $381.49
Upside: +38.93%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $297.05
Upside: +47.79%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $9.55
Upside: -31.94%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $13.85
Upside: -47.65%
Sep 5, 2023
Upgrades: Neutral
Price Target: $79 → $72
Current: $53.99
Upside: +33.36%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $326.31
Upside: +7.26%
Jul 27, 2023
Maintains: Buy
Price Target: $183
Current: $178.08
Upside: +2.76%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $21.95
Upside: +105.01%
Apr 28, 2023
Maintains: Buy
Price Target: $69 → $74
Current: $122.20
Upside: -39.44%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.39
Upside: +62.24%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $15.27
Upside: +129.21%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.76
Upside: +262.32%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $12.79
Upside: -41.36%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $32.25
Upside: -44.19%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $14.03
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $28.00
Upside: -32.14%